22BRO713 : Clinical feasibility of (ATAC-array + HNF1b IHC) as a diagnostic test to predict the first-line chemotherapy response in pancreatic cancer

Principal Investigator

Gabriel Brooks

Study Number

STUDY02001713

Phase

N/A

Available at the following location(s)

• Lebanon

Do you need help with some of the labels on this page?
Read our glossary of terms